Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adam Kibel, M.D.

Co-Author

This page shows the publications co-authored by Adam Kibel and Matthew Mossanen.
Connection Strength

6.795
  1. The bladder cancer conundrum: how do we treat the right tumour with the right treatment, at the right time? BJU Int. 2019 05; 123(5):748-749.
    View in: PubMed
    Score: 0.837
  2. Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy. Eur Urol Oncol. 2018 06; 1(2):143-148.
    View in: PubMed
    Score: 0.783
  3. Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Urol Clin North Am. 2018 May; 45(2):143-154.
    View in: PubMed
    Score: 0.781
  4. Editorial Comment. J Urol. 2018 03; 199(3):712.
    View in: PubMed
    Score: 0.761
  5. Approach to the Patient with High-Risk Prostate Cancer. Urol Clin North Am. 2017 Nov; 44(4):635-645.
    View in: PubMed
    Score: 0.754
  6. Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urol Oncol. 2021 10; 39(10):678-685.
    View in: PubMed
    Score: 0.242
  7. The impact of smoking on radical cystectomy complications increases in elderly patients. Cancer. 2021 05 01; 127(9):1387-1394.
    View in: PubMed
    Score: 0.234
  8. Delayed blood transfusion is associated with mortality following radical cystectomy. Scand J Urol. 2020 Aug; 54(4):290-296.
    View in: PubMed
    Score: 0.226
  9. Risk factors and reasons for reoperation after radical cystectomy. Urol Oncol. 2020 04; 38(4):269-277.
    View in: PubMed
    Score: 0.217
  10. Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis. World J Urol. 2020 Sep; 38(9):2227-2236.
    View in: PubMed
    Score: 0.217
  11. Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy. Urology. 2020 Jan; 135:44-49.
    View in: PubMed
    Score: 0.215
  12. Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis. BJU Int. 2019 07; 124(1):40-46.
    View in: PubMed
    Score: 0.209
  13. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Cancer. 2019 05 01; 125(9):1449-1458.
    View in: PubMed
    Score: 0.205
  14. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol. 2019 Oct; 37(10):2059-2065.
    View in: PubMed
    Score: 0.203
  15. Associations of specific postoperative complications with costs after radical cystectomy. BJU Int. 2018 03; 121(3):428-436.
    View in: PubMed
    Score: 0.189
  16. Exploring exposure to Agent Orange and increased mortality due to bladder cancer. Urol Oncol. 2017 11; 35(11):627-632.
    View in: PubMed
    Score: 0.186
  17. Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic. Minerva Urol Nephrol. 2021 06; 73(3):404-406.
    View in: PubMed
    Score: 0.060
  18. Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma. Urol Oncol. 2021 07; 39(7):436.e1-436.e10.
    View in: PubMed
    Score: 0.060
  19. AUTHOR REPLY. Urology. 2020 Jun; 140:121.
    View in: PubMed
    Score: 0.056
  20. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy. Urology. 2020 Jun; 140:115-121.
    View in: PubMed
    Score: 0.056
  21. Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 12; 18(6):e651-e659.
    View in: PubMed
    Score: 0.056
  22. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years. Cancer. 2020 02 01; 126(3):496-505.
    View in: PubMed
    Score: 0.054
  23. Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. Eur Urol Focus. 2021 01; 7(1):124-131.
    View in: PubMed
    Score: 0.053
  24. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Urol Oncol. 2018 11; 36(11):500.e11-500.e19.
    View in: PubMed
    Score: 0.050
  25. Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA. Eur Urol. 2018 Mar; 73(3):374-382.
    View in: PubMed
    Score: 0.046
  26. Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States. J Urol. 2017 08; 198(2):297-304.
    View in: PubMed
    Score: 0.045
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.